Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | XDH | P47989 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6644948 | 0.86 | KDM4E (0.47) | MAPTTDP1CA12CA1CA2 | |
| SCHEMBL6647182 | 0.86 | MAPT (0.40) | MAPTTDP1SMN1; SMN2SOS1CA12 | |
| SCHEMBL8979022 | 0.86 | KDM4E (0.47) | TDP1SMN1; SMN2SOS1CA12CA1 | |
| SCHEMBL18149338 | 0.86 | KDM4E (0.46) | MAPTSOS1CA12CA1CA2 | |
| SCHEMBL522850 | 0.86 | MAPT (0.44) | MAPTTDP1SOS1CA12CA1 | |
| SCHEMBL2831221 | 0.84 | KDM4E (0.45) | TDP1SOS1CA12CA1CA2 | |
| SCHEMBL17700276 | 0.84 | KDM4E (0.45) | TDP1SOS1CA12CA1CA2 | |
| SCHEMBL7595029 | 0.84 | SOS1 (0.49) | MAPTTDP1SOS1CA12CA1 | |
| SCHEMBL18149676 | 0.84 | SOS1 (0.45) | MAPTTDP1SOS1CA12CA1 | |
| SCHEMBL7491095 | 0.84 | SOS1 (0.45) | MAPTTDP1SOS1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613699-A | Method for removing perfluoro polyether acyl fluoride end group | 南开大学 | 2025-03-14 | — | — | CN | claimed |
| CN-115306376-A | Oil-gas well fracturing monitoring reagent, method and application thereof | 中国石油天然气股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| CN-119613699-A | Method for removing perfluoro polyether acyl fluoride end group | 南开大学 | 2025-03-14 | — | — | CN | disclosed |
| CN-114478520-B | Bcl-2 protein apoptosis inducer and application thereof | 杭州和正医药有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-118955560-A | Light-induced polyfluoroaromatic hydrocarbon phosphonation process | 南京师范大学 | 2024-11-15 | — | — | CN | disclosed |
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230203055-A1 | FUSED RING COMPOUND AND APPLICATION THEREOF IN MEDICINE | BETTA PHARMACEUTICALS CO., LTD (CN) | 2023-06-29 | — | — | US | disclosed |
| CN-115306376-A | Oil-gas well fracturing monitoring reagent, method and application thereof | 中国石油天然气股份有限公司 | 2022-11-08 | — | — | CN | disclosed |
| US-20220298174-A1 | TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD (CN) | 2022-09-22 | — | — | US | disclosed |
| EP-4011886-A1 | TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) | 2022-06-15 | — | — | EP | disclosed |
| CN-102603531-A | Method for preparing 2,3,4,5-tetrafluoro methyl benzoate in series reaction | XIANJU LITIAN CHEMICAL CO LTD | 2012-07-25 | — | — | CN | disclosed |
| CN-102603531-A | Method for preparing 2,3,4,5-tetrafluoro methyl benzoate in series reaction | XIANJU LITIAN CHEMICAL CO LTD | 2012-07-25 | — | — | CN | disclosed |
| US-20110172336-A1 | FLUOROCOPOLYMER COMPOSITION AND ITS PRODUCTION PROCESS | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-07-14 | — | — | US | disclosed |
| EP-2338935-A1 | FLUORINE-CONTAINING COPOLYMER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-06-29 | — | — | EP | disclosed |
| EP-0877011-A1 | Processes for producing tetra-fluorophthalic anhydride and fluorobenzoic acids | ASAHI GLASS COMPANY LTD. (JP) | 1998-11-11 | — | — | EP | disclosed |
| EP-0866050-A1 | Processes for producing tetra-fluorophthalic anhydride and fluorobenzioc acids | ASAHI GLASS COMPANY LTD. (JP) | 1998-09-23 | — | — | EP | disclosed |
| US-5648504-A | MULTISTAGE PROCESS WITH CHLORINATION OF TETRACHLOROPHTHALIC ANHYDRIDE TO 3,3,4,5,6,7-HEXACHLORO-1-(3H)-ISOBENZOFURANONE THEN FLUORINATION AND REACTING WITH INORGANIC BASE OR ACID | ASAHI GLASS COMPANY LTD. (JP) | 1997-07-15 | — | — | US | disclosed |
| US-5523476-A | Processes for producing tetrafluorophthalic anhydride and fluorobenzoic acids | ASAHI GLASS COMPANY LTD. (JP) | 1996-06-04 | — | — | US | disclosed |
| EP-0669310-A1 | Processes for producing tetrafluorophtahlic anhydride and fluorobenzoic acids | ASAHI GLASS COMPANY LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203055-A1 | FUSED RING COMPOUND AND APPLICATION THEREOF IN MEDICINE | VIP, CYP11B2, CYP11B1 | MAPT 4055/4885TDP1 4192/4885SMN1; SMN2 4479/4885 |
| US-20220298174-A1 | TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | KRAS, NRAS, HRAS | MAPT 3413/4885TDP1 3750/4885SMN1; SMN2 4358/4885 |
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AFF4, AFF1, AFF2 | MAPT 2274/4885TDP1 3118/4885SMN1; SMN2 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.